Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
699.80
+41.80 (6.35%)
Apr 29, 2026, 3:29 PM IST

Remus Pharmaceuticals Company Description

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceuticals products and allied products in India and internationally.

It is involved in trading of active pharmaceutical ingredient, as well as provides technical and consultancy services to various distributors and contract manufacturing services.

The company offers tablet, hard and soft gelatine capsules, liquid and lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays and solutions, eye drops, creams, gels, ointments, suspensions, oral solutions and suspensions, sachets, and ophthalmic and other dosage forms.

It also exports its products. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Remus Pharmaceuticals Limited
Country India
Founded 2015
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 68
CEO Arpit Shah

Contact Details

Address:
1101 to 1103, South Tower
Ahmedabad, Gujarat 380054
India
Phone 91 79 2999 9857
Website remuspharma.com

Stock Details

Ticker Symbol REMUS
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE0O5T01011
SIC Code 5122

Key Executives

Name Position
Arpit Shah Chief Executive Officer
Anjali Shah Chief Financial Officer